IL2 and neoplasm: Sec-MesoCAR-T cells showed an enhanced inhibitory effect on BxPC-3 tumor than MesoCAR-T cells in vitro and in vivo, and secreted higher level of cytokines including IL-2, IL-6 and IFN-γ in vitro than MesoCAR-T (control) cells.